See product citations (12)
QUICK LINKS
HNMPA-(AM)3 is a cell-permeable analog of HNMPA that, once inside cells, is converted into its original form by esterase action. This compound acts as an inhibitor of the insulin receptor tyrosine kinase, effectively hindering the autophosphorylation process of the human insulin receptor on tyrosine residues. Additionally, it serves as a small molecule inhibitor aimed at the N-methyl-D-aspartate (NMDA) receptor, which is in the study of neurodegenerative conditions. By blocking the activation of this receptor, HNMPA-(AM)3 helps in reducing the harmful effects associated with excessive glutamate levels, such as excitotoxicity and oxidative stress, factors known to contribute to neurodegenerative diseases. Furthermore, it plays a role in neuronal differentiation and cognitive function by binding to its specific receptor, thereby controlling the influx of calcium ions into cells, which, if unregulated, can lead to cell damage.
Ordering Information
Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
HNMPA-(AM)3, 5 mg | sc-221730 | 5 mg | $186.00 |